Jason Gross

Jason Gross

Chief Tech/Sci/R&D Officer chez HLS THERAPEUTICS INC.

Fortune : 24 638 $ au 31/03/2024

59 ans
Health Technology
Finance
Consumer Services

Profil

Jason A.
Gross
is currently working as the Vice President-Scientific Affairs at HLS Therapeutics, Inc. He started this position in 2014.
Previously, he worked as the Vice President-Scientific & Medical Affairs at Cipher Pharmaceuticals, Inc. from 2012 to 2013.
He also held the position of Vice President at Lumira Capital Investment Management, Inc. Additionally, he worked as the VP-Scientific & Medical Affairs at IVAX Pharmaceuticals, Inc. and as the VP-Regulatory Affairs & Quality Assurance at Drugabuse Sciences, Inc. Dr. Gross obtained a doctorate degree from the University of Arizona.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
08/11/2023 8 409 ( 0,03% ) 24 638 $ 31/03/2024

Postes actifs de Jason Gross

SociétésPosteDébut
HLS THERAPEUTICS INC. Chief Tech/Sci/R&D Officer 01/06/2014
Tous les postes actifs de Jason Gross

Anciens postes connus de Jason Gross

SociétésPosteFin
Private Equity Investor 31/03/2006
Corporate Officer/Principal -
Chief Tech/Sci/R&D Officer -
Drugabuse Sciences, Inc. General Counsel -
CIPHER PHARMACEUTICALS INC. Chief Tech/Sci/R&D Officer -
Voir l'expérience en détail de Jason Gross

Formation de Jason Gross

University of Arizona Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Jason Gross

Relations

22

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
CIPHER PHARMACEUTICALS INC.

Health Technology

HLS THERAPEUTICS INC.

Health Technology

Entreprise privées4

Finance

Health Technology

Drugabuse Sciences, Inc.

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Jason Gross